Session 2 Replay : The Proactive Myeloma Patient: Putting Key Myeloma Research & Treatment News Into Perspective

Published on

Topics include: Treatment and Understanding

Watch the replay of session two of our “The Proactive Myeloma Patient: Putting Key Myeloma Research & Treatment News” town meeting, as a panel of myeloma experts, including Drs. Jonathan L Kaufman, Ajay Nooka and Rafael Fonseca as they discuss the latest news on the myeloma treatment and research landscape. Watch to learn more about emerging myeloma therapies, data on relapse and disease monitoring. Don’t miss myeloma patients Tamara Mobley and Dana Davis also share their stories and take us through thier myeloma journey. Watch as experts breakdown the latest research and help us understand how to move science ahead.

This town meeting is sponsored by Amgen, Janssen Pharmaceuticals and Adaptive Biotechnologies. It is produced by Patient Power in partnership with Winship Cancer Institute of Emory University.

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

View more programs featuring , , , , and

Produced in association with Winship Cancer Institute

Related Programs

How Aggressive Should Smoldering Myeloma Treatment Be?

What kind of treatment do smoldering myeloma patients require? Can early intervention make a difference in prognosis? Watch now as our panel of dedicated researchers explain.

Published:

How Does Adjusting the Dose of My Myeloma Treatment Affect Blood Counts?

Dr. Jadin Shah answers an Ask the Expert question on dose adjustments affecting blood counts in a multiple myeloma patient.

Published:

Why Bisphosphonates Are an Important Tool in Myeloma Treatment

Dr. Robert Orlowski and Dr. Paul Richardson discuss bisphosphonates related to myeloma treatment. They review the concept of bisphosphonates, including the benefits and the duration for which these therapies should be used.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on September 26, 2018